Affected and non-affected skin fibroblasts from systemic sclerosis patients share a gene expression profile deviated from the one observed in healthy individuals

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 866-874

  Fuzii, Hellen T ^a   Yoshikawa, Gilberto T ^a   Junta, Cristina M ^b   Sandrin Garcia, Paula ^b   Fachin, Ana L ^b   Sakamoto Hojo, Elza T ^b   Donadi, Eduardo A ^b   Passos, Geraldo A S ^b   Andrade, Luis E C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cDNA microarrays; Fibroblast; Gene expression; Systemic sclerosis

Indexed keywords

CAPTOPRIL; COMPLEMENTARY DNA; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LIDOCAINE; NIFEDIPINE; PENICILLAMINE;

ADULT; ARTICLE; AXILLARY ARTERY; CELL CULTURE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOREARM; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LABELING INDEX; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCLERODERMA, DIFFUSE; SKIN; UP-REGULATION; YOUNG ADULT;

EID: 57249108547     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. SAPADIN A, ESSER AC, FLEISSCHMAJER R: Immunopathogenesis of Scleroderma - Evolving Concepts. Mt Sinai J Med 2001; 68: 233-42.
2. FLEISCHMAJER R, JACOBS L, SCHWARTZ E et al.: Extracellular microfibrils are increased in localized and systemic scleroderma skin. Lab Invest 1991; 64: 791-8.
3. RUDNICKA L, VARGA J, CHRISTIANO AM et al.: Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest 1994; 93: 1709-15.
4. OLIVER NA: Altered production of fibronectin and collagen in hypercortisolism may inhibit tissue repair. Arch Dermatol 1987; 123: 570-1.
5. LACOUR JP, VITETTA A, CHIQUET-EHRISMANN R et al.: Increased expression of tenascin in the dermis in scleroderma. Br J Dermatol 1992; 127: 328-34.
6. LANGHOLZ O, ROCKEL D, MAUCH C et al.: Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 1995; 131: 1903-15.
7. TROJANOWSKA M, LEROY EC, ECKES B et al.: Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med 1998; 76: 266-74.
8. VUORIO TK, KAHARI VM, LEHTONEN A et al.: Fibroblast activation in scleroderma. Scand J Rheumatol 1984; 13: 229-37.
9. ZHOU X, TAN FK, XIONG M et al.: Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol 2001; 167: 7126-33.
10. WHITFIELD ML, FINLAY D, MURRAY JI et al.: Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 2003; 100: 12319-24.
11. TAN FK, HILDEBRAND BA, LESTER MS et al.: Classification analysis of the transcriptosome of non-affected cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum 2005; 523: 865-76.
12. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
13. CLEMENTS P, LACHENBRUCH P, SIEBOLD J et al.: Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
14. LENNON G, AUFFRAY C, POLYMEROPOULOS M et al.: The IMAGE Consortium: An Integrated Molecular Analysis of Genomes and Their Expression. Genomics 1996; 333: 15-2.
15. HEGDE P, QI R, ABERNATHY K et al.: A concise guide to cDNA microarray analysis. Biotechniques 2000; 29: 548-56.
16. QUACKENBUSH J: Microarray data normalization and transformation. Nat Genet 2002; 32 (Suppl): 496-501.
17. LEUNG YF AND CAVALIERI D: Fundamentals of cDNA microarray data analysis. Trends Genet 2003; 19: 649-59.
18. YANG YH, DUDOIT S, LUU P et al.: Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: E15.
19. EISEN MB, SPELLMAN PT, BROWN PO et al.: Genetics Cluster analysis and display of ge-Home-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-8.
20. TUSHER VG, TIBSHIRANI R, CHU G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-21.
21. BUSTIN SA, BENES V, NOLAN T, PFAFFL MW: Quantitative real-time RT-PCR - a perspective. J Mol Endocrinol 2005; 34: 597-601.
22. VANDESOMPELE J, DE PRETER K, PATTYN F et al.: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: research0034,1-0034.11.
23. KURODA K, SHINKAI H: Gene Expression of Type I and III collagen, decorin, matrix metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997; 289: 567-72.
24. ZHOU X, TAN FK, XIONG M: Monozygotic twins clinically discordant for scleroderrna show concordance for fibroblast gene expression profiles. Arthritis Rheum 2005; 52: 3305-14.
25. PENDERGRASS SA, WHITFIELD ML, GARDNER H: Understanding systemic sclerosis through gene expression profiling. Curr Opin Rheumatol 2007; 19: 561-7.
26. GARDNER H, SHEARSTONE JR, BANDARU R et al.: Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum 2006; 54: 1961-73.
27. CHOU JY: Production of pregnancy-specific beta 1-glycoprotein by human placental cells and human fibroblasts. Oncodev Biol Med 1983; 4: 319-26.
28. CHOU JY, SARTWELL AD, WAN YJ: Characterization of pregnancy-specific beta 1-glycoprotein synthesized by human placental fibroblasts. Mol Endocrinol 1989; 3: 89-96.
29. SNYDER SK, WESSNER DH, WESSELLS JL et al.: Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am J Reprod Immunol 2001; 45: 205-16.
30. WHITESIDE TL, KUMAGAI Y, ROUMM AD et al.: Suppressor cell function and T lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis. Arthritis Rheum 1983; 26: 841-7.
31. KANTOR TV, FRIBERG D, MEDSGER TA et al.: Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 1992; 65: 278-85.
32. KOMETANI K, ISHIDA D, HATTORI M et al.: Rap1 and SPA-1 in hematologic malignancy. Trends Mol Med 2004; 10: 401-8.
33. MIKI H, OKADA Y, HIROKAWA N: Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 2005; 15: 467-76.
34. NAKAJIMA K, TAKEI Y, TANAKA Y et al.: Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport. Mol Cell Biol 2002; 22: 866-73.
35. TIAN XL, KADABA R, YOU SA et al.: Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 2004; 427: 640-5.
36. KIKUCHI K, KUBO M, HOASHI T et al.: Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis. Clin Exp Dermatol 2002; 27: 301-5.
37. KIM WU, MIN SY, CHO ML et al.: Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res 2005; 7: R71-9.
38. KRIEF P, AUGERY-BOURGET Y, PLAISANCE S et al.: A new cytokine (IK) down-regulating HLA class II: Monoclonal antibodies, cloning and chromosome localization. Oncogene 1994; 9: 3449-56.
39. VEDRENNE J, ASSIER E, PERENO R et al.: Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line. Oncogene 1997; 14: 1453-61.
40. BRANCHET MC, BOISNIC S, BLETRY O et al.: Expression of HLA class II antigens on skin fibroblasts in scleroderma. Br J Dermatol 1992; 126: 431-5.